Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
EXACT Therapeutics AS ( (DE:56F) ) has provided an announcement.
EXACT Therapeutics AS has launched a new long-term incentive program involving share options, which will replace the current incentive program. This initiative aims to align the interests of participants, including primary insiders, with the company’s performance, potentially impacting its operational dynamics and stakeholder engagement.
More about EXACT Therapeutics AS
EXACT Therapeutics AS is a clinical-stage precision medicine company that leverages ultrasound and microbubbles for targeted drug delivery, particularly in oncology. Its Acoustic Cluster Therapy (ACT®) is designed to enhance the effectiveness of therapeutic agents across various indications, including chemotherapy, immunotherapy, and brain diseases.
YTD Price Performance: -46.81%
Average Trading Volume: 46,170
Current Market Cap: NOK126.5M
For detailed information about 56F stock, go to TipRanks’ Stock Analysis page.